The $50k Challenge Update 12 – 06/07/2020
Stock Code: CDX
Shares Purchased: 480,000
Share Price: 0.025
Reasons for Buying:
- Company looking to achieve cash flow break even by the end of 2020 based on strong uptrend in revenue.
- Multiple new partnerships announced over the past 6 months to extend the reach of CDX in the telehealth sector.
- The telehealth sector has experienced significant growth due to the Coronavirus pandemic. By all accounts, this trend will continue to grow over the coming years.
- CDX signed a co-development agreement with Blumio as well as gaining a 7.5% holding of Blumio. Blumio is a company who is back by American Billionaire Peter Thiel.
- Top 20 shareholder own 51% of the register.
- The CEO is the number 1 shareholder owning 20% of the register. Total director holdings amount to 40% of the register.
Risks:
- Company is using a combination of convertible notes as well as a financing agreement to fund its operations in the medium term. An equity raise is likely to happen in the medium term.
- The multiple partnerships that they have are exciting but obviously there are no guarantees that they will succeed.
Please remember all content is intended to be used and must be used for informational purposes only. It is very important to do your own analysis before making any investment based on your own personal circumstances. You should take independent financial advice from a professional in connection with, or independently research and verify, any information that you find on our Website and wish to rely upon, whether for the purpose of making an investment decision or otherwise.